Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
– Sell
-13,500
Closed -$81K – 7044
2014
Q4
$81K Sell
13,500
-3,000
-18% -$18.9K ﹤0.01% 5360
2014
Q3
$99K Hold
16,500
– – ﹤0.01% 5338
2014
Q2
$116K Hold
16,500
– – ﹤0.01% 5304
2014
Q1
$116K Sell
16,500
-39,000
-70% -$273K ﹤0.01% 5308
2013
Q4
$389K Buy
+55,500
New +$406K ﹤0.01% 4346

Other funds holding ABEV

Barclays's ABEV Position: Q3 2026 in Review

Barclays increased its Ambev (ABEV) stake by 12% in Q3 2026, buying an estimated $59.7K and bringing the position to 184,632 shares worth $539K. The position accounts for ﹤0.01% of the portfolio, ranked #3415.

Barclays first reported a position in ABEV in Q4 2013 and has held it in 44 quarters since. The position peaked at $12.9M in Q3 2015. 234 funds tracked by Wall St. Rank hold ABEV as of Q3 2026.

  • Barclays held 184,632 shares of Ambev worth $539K as of Q3 2026.
  • Barclays bought 20,010 Ambev shares in Q3 2026, an estimated $59.7K.
  • Ambev made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #3415 holding.
  • Barclays first reported a position in Ambev in Q4 2013 and has held it in 44 quarters since.
  • Barclays's Ambev position peaked at $12.9M in Q3 2015.
  • 234 funds tracked by Wall St. Rank held Ambev as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.